PTX 4.44% 4.7¢ prescient therapeutics limited

Ann: PTX strategic collaboration with MD Anderson Cancer Center, page-29

  1. 452 Posts.
    lightbulb Created with Sketch. 66
    So here it begins.
    SYC has always alluded to an app store type of scenario.
    In some ways there are parallels to Apple. This might not be the best analogy to compare apples with apples, but similarities none the less, that SYC has given in the many recent presentations.
    Apple has a first in class technology and platform, with its iPhone. PTX is developing best in class new generation OmniCar CAR-T platform.
    Apple charges the end users to use the platform (buy the iPhone) then controls its app store and charges app developers to use its platform (fees), for best in class technology and software (apps).
    PTX has begun to collaborate with CAR-T developers (MD Anderson being the first, let the dominos keep falling) to integrate their plug-n-play platform (OmniCar) with binder technology developed by CAR-T entities. PTX receives a future fee upon success of such binders.
    PTX sees a future where end users (lets say government subsidies) pay to use OmniCar and also manufacturers use the OmniCar platform and pay a fee for plug-n-play binders to be incorporated into the platform.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.7¢
Change
0.002(4.44%)
Mkt cap ! $37.44M
Open High Low Value Volume
4.5¢ 4.7¢ 4.5¢ $38.21K 837.8K

Buyers (Bids)

No. Vol. Price($)
5 43858 4.6¢
 

Sellers (Offers)

Price($) Vol. No.
4.7¢ 136366 4
View Market Depth
Last trade - 14.48pm 03/06/2024 (20 minute delay) ?
Last
4.7¢
  Change
0.002 ( 4.44 %)
Open High Low Volume
4.5¢ 4.7¢ 4.5¢ 294732
Last updated 15.11pm 03/06/2024 ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.